Beijing Luzhu Biotechnology Co., Ltd. (02480)
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant hum
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
